NIAID Strategic Plan for COVID-19 Research, FY2020-FY2024

Publication Date

April 22, 2020

Page Number

10

Link to Report

Download

Download

Authors

NIAID, part of the US National Institutes of Health, “is committed to safeguarding the health of Americans and people around the world by accelerating research efforts to prevent, diagnose, and treat COVID-19.” This strategic plan, structured around four research priorities, “builds on current trans-NIAID efforts to better understand SARS-CoV-2 pathogenesis, transmission, and mechanisms of protective immunity.”

  1. Improve fundamental knowledge about the virus;
  2. Support development of diagnostics and seriologic assays;
  3. Characterize and test therapeutics;
  4. Develop safe and effective vaccines, and advance promising candidates through clinical trials.

Note: NIAID is directed by Dr. Anthony S. Fauci, widely-known to Americans as the leading expert in this field. Also, see McKinsey & Company “COVID-19 Briefing Materials”, noting >80 vaccine candidates and 130 therapeutic candidates being considered as of April 13.  NIAID is directed by Dr. Anthony S. Fauci, widely-known to Americans as the leading expert in this field.

Share and follow us via:

Recent Articles:

  • Our world is in the midst of multiple crises, aggravated by the COVID-19 pandemic and the war in Ukraine.  This includes a crisis in education and learning, notably at K-12…

  • Introduction While fossil fuels continue to dominate energy production and consumption, the press of climate change has made it abundantly clear that the ecological costs of greenhouse gas emitting power…

  • Young leaders are not just aspiring leaders of the future, but, in recent decades, appear as major factors in raising awareness of and popularizing the most urgent problems of our…